Latest News from the WHO Executive Board Session in Geneva – WFH
World Federation of Hemophilia (WFH) shared on LinkedIn:
”Latest news from the WHO Executive Board session in Geneva
Today, the World Health Organization Executive Board (EB158) discussed a historic draft resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders.
The World Federation of Hemophilia (WFH) commends the leadership of the Republic of Armenia and all co-sponsoring Member States — Bosnia and Herzegovina, Egypt, Georgia, Iraq, Latvia, Malta, Morocco, Nepal, Paraguay, Spain, Sri Lanka, and Togo — for proposing this landmark resolution for consideration at EB158.
We also thank the additional Member States that expressed their support.
This marked the first-ever discussion on hemophilia and other bleeding disorders at the WHO Executive Board.
During the session, Salome Mekhuzla, WFH Director of Global Development, delivered a statement in support of adopting the resolution.
Watch the full Executive Board discussion here.
The WHO Executive Board is expected to make a final decision on the resolution tomorrow, February 3.
Stay tuned for a major update from WFH.”
Stay updated with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis